{"entity":{"type":"insider","cik":"0001372218","url":"/insider/0001372218","json_url":"/insider/0001372218.json","name":"CPMG Inc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":170,"n_filings":35,"first":"2006-08-23","last":"2021-10-19","span_basis":"filed_date"},"name_variants":[{"name":"CPMG Inc","source":"filing","n_filings":35,"first_seen":"2006-08-23","last_seen":"2021-10-19"}],"transactions":[{"id":5355016,"accession":"0001140361-21-034927","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-034927","line_url":"/filing/0001140361-21-034927","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":683871.0,"shares_display":"683,871","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":5300000.25,"total_display":"5,300,000.25","total_whole":"5,300,000","shares_owned_after":2151209.0,"shares_owned_after_display":"2,151,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider","n_lines":3},{"id":5079374,"accession":"0001628280-21-018953","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-018953","line_url":"/filing/0001628280-21-018953#line-2","is_derivative":false,"issuer_cik":"0001372218","issuer_name":"PROCEPT BioRobotics Corp","issuer_ticker":"PRCT","issuer_name_source":null,"issuer_url":"/issuer/0001372218","owner_cik":null,"owner_name":"CPMG Inc; White Tailed Ptarmigan, LP; McGaughy R Kent Jr","owner_display_name":"CPMG Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440000.0,"shares_display":"440,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":11000000.0,"total_display":"11,000,000.00","total_whole":"11,000,000","shares_owned_after":11222662.0,"shares_owned_after_display":"11,222,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":2102281,"accession":"0000905148-20-000825","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-20-000825","line_url":"/filing/0000905148-20-000825","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1780000.0,"shares_display":"1,780,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":2225000.0,"total_display":"2,225,000.00","total_whole":"2,225,000","shares_owned_after":1707208.0,"shares_owned_after_display":"1,707,208","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-07-21","scope":"insider","n_lines":3},{"id":8762291,"accession":"0000905148-19-001001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-19-001001","line_url":"/filing/0000905148-19-001001","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40218.0,"shares_display":"40,218","price_per_share":183.0,"price_display":"183.00","price_state":"stated","total_value":7359894.0,"total_display":"7,359,894.00","total_whole":"7,359,894","shares_owned_after":137962.0,"shares_owned_after_display":"137,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider","n_lines":4},{"id":6138340,"accession":"0000905148-18-000920","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000905148-18-000920","line_url":"/filing/0000905148-18-000920#line-5","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1418.0,"shares_display":"1,418","price_per_share":59.8952,"price_display":"59.90","price_state":"stated","total_value":84931.3936,"total_display":"84,931.39","total_whole":"84,931","shares_owned_after":281918.0,"shares_owned_after_display":"281,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-12","scope":"insider"},{"id":6138337,"accession":"0000905148-18-000920","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-18-000920","line_url":"/filing/0000905148-18-000920#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52809.0,"shares_display":"52,809","price_per_share":60.0719,"price_display":"60.07","price_state":"stated","total_value":3172336.9671,"total_display":"3,172,336.97","total_whole":"3,172,337","shares_owned_after":109408.0,"shares_owned_after_display":"109,408","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider"},{"id":6138334,"accession":"0000905148-18-000920","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-18-000920","line_url":"/filing/0000905148-18-000920","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56599.0,"shares_display":"56,599","price_per_share":58.77428468877542,"price_display":"58.77","price_state":"stated","total_value":3326565.7391,"total_display":"3,326,565.74","total_whole":"3,326,566","shares_owned_after":56599.0,"shares_owned_after_display":"56,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider","n_lines":3},{"id":4459406,"accession":"0001140361-17-047821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047821","line_url":"/filing/0001140361-17-047821#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":28.4715,"price_display":"28.47","price_state":"stated","total_value":484015.5,"total_display":"484,015.50","total_whole":"484,016","shares_owned_after":44200.0,"shares_owned_after_display":"44,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2017-12-29","scope":"insider"},{"id":4819117,"accession":"0001140361-17-047647","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-047647","line_url":"/filing/0001140361-17-047647#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":26.1,"price_display":"26.10","price_state":"stated","total_value":5220.0,"total_display":"5,220.00","total_whole":"5,220","shares_owned_after":27200.0,"shares_owned_after_display":"27,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2017-12-28","scope":"insider"},{"id":4819114,"accession":"0001140361-17-047647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-047647","line_url":"/filing/0001140361-17-047647#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":25.8296,"price_display":"25.83","price_state":"stated","total_value":387444.0,"total_display":"387,444.00","total_whole":"387,444","shares_owned_after":27000.0,"shares_owned_after_display":"27,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2017-12-28","scope":"insider"},{"id":4819112,"accession":"0001140361-17-047647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047647","line_url":"/filing/0001140361-17-047647#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":26.0605,"price_display":"26.06","price_state":"stated","total_value":312726.0,"total_display":"312,726.00","total_whole":"312,726","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":9233464,"accession":"0001140361-17-047643","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-047643","line_url":"/filing/0001140361-17-047643#line-3","is_derivative":false,"issuer_cik":"0001372218","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001372218","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14866.0,"shares_display":"14,866","price_per_share":24.6528,"price_display":"24.65","price_state":"stated","total_value":366488.5248,"total_display":"366,488.52","total_whole":"366,489","shares_owned_after":34897.0,"shares_owned_after_display":"34,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-28","scope":"insider"},{"id":5052531,"accession":"0000905148-17-000939","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000905148-17-000939","line_url":"/filing/0000905148-17-000939","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78275.0,"shares_display":"78,275","price_per_share":24.6528,"price_display":"24.65","price_state":"stated","total_value":1929697.92,"total_display":"1,929,697.92","total_whole":"1,929,698","shares_owned_after":431155.0,"shares_owned_after_display":"431,155","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-15","scope":"insider","n_lines":4},{"id":9233463,"accession":"0001140361-17-047643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047643","line_url":"/filing/0001140361-17-047643","is_derivative":false,"issuer_cik":"0001372218","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001372218","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20031.0,"shares_display":"20,031","price_per_share":24.88158104438121,"price_display":"24.88","price_state":"stated","total_value":498402.9499,"total_display":"498,402.95","total_whole":"498,403","shares_owned_after":19982.0,"shares_owned_after_display":"19,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-28","scope":"insider","n_lines":2},{"id":5052515,"accession":"0000905148-17-000939","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000905148-17-000939","line_url":"/filing/0000905148-17-000939","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121725.0,"shares_display":"121,725","price_per_share":24.881564386937768,"price_display":"24.88","price_state":"stated","total_value":3028708.425,"total_display":"3,028,708.42","total_whole":"3,028,708","shares_owned_after":393515.0,"shares_owned_after_display":"393,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-15","scope":"insider","n_lines":8},{"id":5114776,"accession":"0000905148-17-000016","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000905148-17-000016","line_url":"/filing/0000905148-17-000016","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9392.0,"shares_display":"9,392","price_per_share":21.7247,"price_display":"21.72","price_state":"stated","total_value":204038.3824,"total_display":"204,038.38","total_whole":"204,038","shares_owned_after":310747.0,"shares_owned_after_display":"310,747","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-04","scope":"insider","n_lines":7},{"id":2502182,"accession":"0000905148-16-002139","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000905148-16-002139","line_url":"/filing/0000905148-16-002139","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":164753.0,"shares_display":"164,753","price_per_share":22.9909,"price_display":"22.99","price_state":"stated","total_value":3787819.7477,"total_display":"3,787,819.75","total_whole":"3,787,820","shares_owned_after":307937.0,"shares_owned_after_display":"307,937","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider","n_lines":6},{"id":2819090,"accession":"0000905148-16-002131","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000905148-16-002131","line_url":"/filing/0000905148-16-002131#line-10","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1290.0,"shares_display":"1,290","price_per_share":22.0498,"price_display":"22.05","price_state":"stated","total_value":28444.242,"total_display":"28,444.24","total_whole":"28,444","shares_owned_after":243687.0,"shares_owned_after_display":"243,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"},{"id":2819088,"accession":"0000905148-16-002131","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000905148-16-002131","line_url":"/filing/0000905148-16-002131#line-9","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001372218","owner_name":"CPMG Inc","owner_display_name":"CPMG Inc","owner_url":"/insider/0001372218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":579.0,"shares_display":"579","price_per_share":22.0498,"price_display":"22.05","price_state":"stated","total_value":12766.8342,"total_display":"12,766.83","total_whole":"12,767","shares_owned_after":290120.0,"shares_owned_after_display":"290,120","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"}],"collapsed":true,"next_cursor":"2016-12-15|2819088","ledger_fault":false,"count":{"value":148,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":147,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":148},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001251769","name":"Apollo Endosurgery, Inc.","url":"/issuer/0001251769","role":"Ten percent owner","n_filings":2,"first_seen":"2020-07-21","last_seen":"2021-10-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001588978","name":"PROCEPT BioRobotics Corp","url":"/issuer/0001588978","role":"Ten percent owner","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Director, Ten percent owner","n_filings":16,"first_seen":"2016-06-01","last_seen":"2019-11-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001028358","name":"GENITOPE CORP","url":"/issuer/0001028358","role":"Ten percent owner, Other","n_filings":16,"first_seen":"2006-08-23","last_seen":"2008-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001372218","retrieved_at":"2026-08-24T03:02:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}